ECHA to scrutinise all REACH registrations by 2027

Europe – Upcoming changes to REACH information requirements

The update of the REACH annexes clarifies the information companies need to submit in their registrations and makes ECHA’s evaluation practices more transparent and...
Updated guidance for registering substances in nanoform

Europe – Group assessment of bisphenols identifies need for restriction

Many bisphenols are known endocrine disrupters both for human health and the environment. They also have reprotoxic properties. As they are widely used, a...
ECHA to scrutinise all REACH registrations by 2027

Europe – Pharmaceutical industry provides unpublished data on chemical substances

The datasets contain information about the hazard properties of 19 substances from 153 tests. The information can contribute to the development of predictive computational...

Europe – Projet of transfert du SCCS Sous la responsabilité de l’ECHA : COSMED...

Lancée en 2020, la stratégie chimique européenne , vise notamment à optimiser l’évaluation de la sécurité chimique des substances. Pour atteindre cet objectif une...

Europe – Natural and organic cosmetics: An overview of certification options

Interest in natural and organic cosmetics continues to rise amidst a wider green beauty boom, but with little regulation around these two terms, certification...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – SCCS – Request for a scientific opinion on the hair dye ‘Sodium...

The ingredient with the INCI name ‘Sodium Bromothymol Blue’ and chemical name ‘Sodium α- (3-bromo-5-isopropyl-4-oxo-2-methyl-2,5-cyclohexadienylidene)-2-(3-bromo-4-hydroxy-5- isopropyl-2-methylphenyl)toluenesulphonate’ (CAS No. 34722-90-2, EC No. 252-169-7) is a...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – SCCS – Final Opinion on Kojic acid

In light of the data provided and taking under consideration the concerns related to potential endocrine disrupting properties of Kojic acid, does the SCCS consider...

Europe – Endocrine disruptors? SCCS closes comment period on phytoestrogens cosmetics safety

The European Commission’s Scientific Committee for Consumer Safety (SCCS) has closed the comment period for its preliminary safety opinion on the two phytoestrogen isoflavone...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – SCCS : Request for a scientific opinion on Salicylic acid

On 7 November 2018, the Commission adopted the review1 of Regulation (EC) No 1223/2009 on cosmetic products (‘Cosmetics Regulation’) regarding substances with endocrine disrupting...

Europe – SCCS : OPINION on Prostaglandins and prostaglandin-analogues used in cosmetic products

In light of the data provided, does the SCCS consider Isopropyl cloprostenate (CAS 157283-66-4) and Ethyl Tafluprostamide or DDDE (CAS 1185851-52-8) safe when used up to...

NOS PROCHAINES FORMATIONS